Table 1 Known prostate cancer risk SNPs successfully tested in this study
From: Genetic architecture of prostate cancer in the Ashkenazi Jewish population
SNP | Chr. | Gene | Alleles (Maj/Min) | MAF | Prev. OR | Citation |
|---|---|---|---|---|---|---|
rs721048 | 2 | EHBP1 | G/A | 0.19 | 1.15 | |
rs2660753 | 3 | CHMP2B; POU1F1 | C/T | 0.11 | 1.18 | |
rs9364554 | 6 | SLC22A3; SLC22A2; LPAL2; LPA | C/T | 0.29 | 1.17 | |
rs10486567 | 7 | JAZF1 | G/A | 0.23 | 0.74 | |
rs6465657 | 7 | LMTK2; BHLHB8 | T/C | 0.46 | 1.12 | |
rs7008482 | 8 | — | T/G | 0.83 | 1.8 | |
rs1016343 | 8 | — | C/T | 0.18 | 1.37 | |
rs13254738 | 8 | — | A/C | 0.34 | 1.11 | |
rs16901979 | 8 | — | C/A | 0.031 | 1.79 | |
rs6983267 | 8 | — | G/T | 0.50 | 0.8 | |
rs7000448 | 8 | — | C/T | 0.39 | 1.14 | |
rs4242382 | 8 | — | G/A | 0.12 | 1.41 | |
rs4242384 | 8 | — | A/C | 0.09 | 1.88 | |
rs7920517 | 10 | MSMB | G/A | 0.48 | 0.82 | |
rs10993994 | 10 | MSMB | T/C | 0.60 | 0.8 | |
rs4962416 | 10 | CTBP2 | T/C | 0.27 | 1.2 | |
rs7931342 | 11 | — | G/T | 0.49 | 0.84 | |
rs10896449 | 11 | — | G/A | 0.48 | 0.78 | |
rs4430796 | 17 | TCF2 | G/A | 0.49 | 1.24 | |
rs7501939 | 17 | TCF2 | C/T | 0.42 | 0.83 | |
rs1859962 | 17 | — | G/T | 0.54 | 0.8 | |
rs2735839 | 19 | KLK2; KLK3 | G/A | 0.15 | 0.83 | |
rs5945572 | X | NUDT11; NUDT10 | G/A | 0.35 | 1.24 |